| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YIF1A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | ZNF630 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | MADCAM1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CCDC169 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | SLC15A3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | TOR2A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | CCDC154 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ITGB5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | KAT14 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ENTPD8 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
